Overview
Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy
Status:
Completed
Completed
Trial end date:
2010-11-01
2010-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the study is to test whether vaccinations with CYT003-QbG10 can improve allergy symptoms in patients with house dust mite allergy. The active treatment will be compared against placebo.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Cytos Biotechnology AG
Criteria
Inclusion Criteria:- Perennial allergic rhinoconjunctivitis due to clinically relevant allergy towards
house dust mite allergens
- Further criteria as defined in the study protocol
Exclusion Criteria:
- Clinically manifested seasonal allergy/-ies which is/are expected to interfere with
the patient's study treatment schedule and/or assessments
- Clinically relevant perennial allergy/-ies other than house dust mites allergy
- Contraindication to any study test or procedure
- Further criteria as defined in the study protocol